심혈관 의료기기 : 세계 시장(-2030년)

The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.

Report Scope

The report provides an overview of the global cardiovascular devices market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.

The market is segmented by product and end user. Based on product, the cardiovascular devices market is segmented into interventional cardiology, cardiac rhythm management, diagnostics and monitoring, cardiac assist devices, electrophysiology, and other vascular surgery devices. Based on end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.

The report concludes by analyzing the competitive landscape and providing the leading global cardiovascular devices companies. It also includes a dedicated section of company profiles that covers overviews, key financials, product portfolios, and recent developments for major companies.

Report Includes

• 69 data tables and 73 additional tables
• An overview and analysis of the global cardiovascular devices market
• Analyses of global market trends, with revenue data for 2022-2025, and projections of CAGRs through 2030
• Estimates of the current market size and future revenue growth prospects, accompanied by a market share analysis by product, end user, and region
• Facts and figures pertaining to market dynamics, including key drivers, restraints, opportunities, challenges, and the impact of macroeconomic factors
• Review of regulatory frameworks across major regions, along with an assessment of approval pathways and compliance requirements
• Insights into emerging technologies and developments, including innovations in minimally invasive devices, remote patient monitoring, and implantable cardiovascular technologies
• Patent analysis highlighting key granted and published patents related to cardiovascular medical devices
• Analysis of the competitive landscape, including company market share rankings, strategic initiatives, partnerships, and recent developments
• Overview of sustainability trends and ESG developments in the global cardiovascular devices market
• Profiles of the leading global companies, including Medtronic, Abbott, Boston Scientific Corp., Edwards Lifesciences Corp., and Johnson & Johnson

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Technological Advances
• Conclusion

Chapter 2 Market Overview

• Overview
• Type of Cardiovascular Diseases
• Coronary Artery Disease
• Arrhythmia
• Structural Heart Disease
• Heart Infection
• Cardiovascular Procedures Volume
• Cardiovascular Procedures Cost
• Porter's Five Forces Analysis in the Technologies for Cardiovascular Devices Market
• Potential for New Entrants (Low to Moderate)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Low)
• Competition in the Industry (High)
• Macroeconomic Factor Analysis
• Urbanization and Lifestyle Changes
• Shortage of Skilled Professionals
• U.S. Tariff Scenario

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Prevalence of Cardiovascular Disorders and Other Lifestyle-Related Disorders
• Growing Demand for Minimally Invasive Procedures in Cardiovascular Treatment
• Increasing Adoption of Remote Patient Monitoring for Cardiac Disease Management
• Market Restraints
• Stringent Product Approval Guidelines
• High Cost of Advanced Cardiovascular Devices and Procedures
• Market Opportunities
• Growing Demand for Preventive and Early-Diagnosis Solutions
• Increasing Focus on Value-Based Healthcare
• Market Challenges
• Complex Product Development
• Complications Associated with Implantable Devices

Chapter 4 Regulatory Landscape

• U.S.
• Europe
• Other Regions

Chapter 5 Emerging Technologies and Developments

• Emerging Technologies
• Leadless and Wireless Cardiac Implants
• Bioresorbable Cardiac Devices
• Wearable Cardiac Devices
• Total Artificial Heart
• Artificial Intelligence
• Patent Analysis
• Key Takeaways
• Patents, by Year
• By Top Applicant
• By Top Owner
• By Jurisdiction

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product
• Key Takeaways
• Interventional Cardiology
• Cardiac Rhythm Management
• Diagnostics and Monitoring
• Cardiac Assist Devices
• Electrophysiology
• Other Vascular Surgery Devices
• Market Analysis by End User
• Key Takeaways
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Diagnostics Laboratories
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Leading Companies in the Global Cardiovascular Devices Market
• Medtronic
• Abbott
• Boston Scientific Corp
• Edward
• Johnson & Johnson
• Key Developments and Strategies

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBOTT
• BAXTER
• B. BRAUN SE
• BIOTRONIK
• BOSTON SCIENTIFIC CORP.
• BPL MEDICAL TECHNOLOGIES
• COOK
• EDWARDS LIFESCIENCES CORP.
• GE HEALTHCARE
• JOHNSON & JOHNSON
• KONINKLIJKE PHILIPS N.V.
• MEDTRONIC
• NIHON KOHDEN CORP.
• SIEMENS HEALTHINEERS AG
• TERUMO CORP.
• Few Emerging Start-Ups/ Market Disruptors